HUE052968T2 - Liposzóma kompozíció és annak elõállítási eljárása - Google Patents

Liposzóma kompozíció és annak elõállítási eljárása

Info

Publication number
HUE052968T2
HUE052968T2 HUE15785362A HUE15785362A HUE052968T2 HU E052968 T2 HUE052968 T2 HU E052968T2 HU E15785362 A HUE15785362 A HU E15785362A HU E15785362 A HUE15785362 A HU E15785362A HU E052968 T2 HUE052968 T2 HU E052968T2
Authority
HU
Hungary
Prior art keywords
production method
method therefor
liposome composition
liposome
composition
Prior art date
Application number
HUE15785362A
Other languages
English (en)
Inventor
Makoto Ono
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of HUE052968T2 publication Critical patent/HUE052968T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome
HUE15785362A 2014-04-30 2015-04-30 Liposzóma kompozíció és annak elõállítási eljárása HUE052968T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014094140 2014-04-30

Publications (1)

Publication Number Publication Date
HUE052968T2 true HUE052968T2 (hu) 2021-05-28

Family

ID=54358710

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15785362A HUE052968T2 (hu) 2014-04-30 2015-04-30 Liposzóma kompozíció és annak elõállítási eljárása

Country Status (14)

Country Link
US (3) US10391057B2 (hu)
EP (1) EP3138555B1 (hu)
JP (1) JP6251385B2 (hu)
CY (1) CY1123731T1 (hu)
DK (1) DK3138555T3 (hu)
ES (1) ES2836772T3 (hu)
HR (1) HRP20202030T1 (hu)
HU (1) HUE052968T2 (hu)
LT (1) LT3138555T (hu)
PL (1) PL3138555T3 (hu)
PT (1) PT3138555T (hu)
RS (1) RS61273B1 (hu)
SI (1) SI3138555T1 (hu)
WO (1) WO2015166986A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3138557B1 (en) * 2014-04-30 2023-06-07 FUJIFILM Corporation Liposome composition and method for producing same
ES2836772T3 (es) * 2014-04-30 2021-06-28 Fujifilm Corp Composición liposomal y método para producirla
EP3372223B1 (en) * 2015-11-02 2024-04-17 FUJIFILM Corporation Liposome composition and method for producing same
TW202015703A (zh) 2018-06-20 2020-05-01 日商富士軟片股份有限公司 包含內含吉西他濱之脂質體組成物及免疫檢查點抑制劑之組合醫藥
WO2021201267A1 (ja) 2020-04-03 2021-10-07 富士フイルム株式会社 抗腫瘍剤

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US4970074A (en) 1987-06-29 1990-11-13 Abbott Laboratories Fluorophores for encapsulation into liposomes
US5328678A (en) 1987-11-04 1994-07-12 Vestar, Inc. Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy
DE68901733T2 (de) 1988-03-04 1993-03-25 Takeda Chemical Industries Ltd Liposom-zusammensetzung.
JP2931981B2 (ja) 1988-03-04 1999-08-09 武田薬品工業株式会社 リポソーム製剤およびその製造法
US5049392A (en) 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
US5227170A (en) 1989-06-22 1993-07-13 Vestar, Inc. Encapsulation process
IS1685B (is) 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
JPH069374A (ja) * 1992-04-07 1994-01-18 Banyu Pharmaceut Co Ltd リポソ−ム製剤およびその製造法
CA2093381A1 (en) * 1992-04-07 1993-10-08 Hideyuki Sawahara Liposome formulation and process for production thereof
JPH08505882A (ja) * 1993-11-05 1996-06-25 アムジエン・インコーポレーテツド リポソーム調製法及び物質のカプセル化方法
CA2137297C (en) 1993-12-06 2000-04-18 Tsuyoshi Miyazaki Reactive vesicle and functional substance-fixed vesicle
US6261597B1 (en) 1995-08-31 2001-07-17 Seymour J. Kurtz Method for treating periodontal disease
DE69631970T2 (de) * 1995-12-15 2005-04-14 National Research Council Of Canada, Ottawa Archaeoliposome, Koenzym Q10 enthaltende Archaeoliposome und Koenzym Q10 enthaltende Liposome als Adjuvans und Wirkstoffabgabevehikel
US6056973A (en) 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
US8518437B2 (en) * 2001-11-13 2013-08-27 Celator Pharmaceuticals, Inc. Lipid carrier compositions with enhanced blood stability
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
CA2505520C (en) 2002-11-06 2012-07-17 Azaya Therapeutics, Inc. Protein-stabilized liposomal formulations of pharmaceutical agents
EP1608337A2 (en) 2003-04-02 2005-12-28 Celator Technologies Inc. Combination compositions of camptothecins and fluoropyrimidines
WO2005000266A2 (en) 2003-05-22 2005-01-06 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
JPWO2005021012A1 (ja) * 2003-08-29 2006-10-26 テルモ株式会社 ゲムシタビン封入薬剤担体
EP3173073A1 (en) 2004-05-03 2017-05-31 Merrimack Pharmaceuticals, Inc. Liposomes for drug delivery
NZ551406A (en) 2004-06-03 2010-03-26 Hoffmann La Roche Treatment of non small cell lung cancer with gemcitabine and erlotinib (an egfr kinase inhibitor)
WO2006032136A1 (en) * 2004-09-20 2006-03-30 British Columbia Cancer Agency Branch Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin
CN109485727A (zh) 2005-05-09 2019-03-19 小野药品工业株式会社 程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法
JPWO2006137377A1 (ja) * 2005-06-22 2009-01-22 独立行政法人理化学研究所 神経再生促進剤
US20070014845A1 (en) * 2005-07-01 2007-01-18 Yuanpeng Zhang Liposomal delivery vehicle for hydrophobic drugs
US20070178147A1 (en) 2005-12-08 2007-08-02 Desai Narendra R Liposomal compositions
US8119156B2 (en) 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
JP5080779B2 (ja) 2006-10-25 2012-11-21 テルモ株式会社 リポソーム製剤の製造方法
CN101209243B (zh) 2006-12-29 2010-12-08 石药集团中奇制药技术（石家庄）有限公司 一种脂质体药物及其制备方法
CN100496609C (zh) 2006-12-30 2009-06-10 上海艾力斯医药科技有限公司 一种稳定的脂质体组合物
US20100239652A1 (en) 2007-09-28 2010-09-23 Universitatsspital Basel Immunoliposomes for treatment of cancer
JP5479453B2 (ja) 2008-04-17 2014-04-23 ザ・ジョンズ・ホプキンス・ユニバーシティ ＯＮ０１９１０．Ｎａは薬剤耐性腫瘍において化学療法剤活性を増強する
US8231895B2 (en) 2008-05-22 2012-07-31 Universidade De Coimbra Targeted delivery to human diseases and disorders
CN101444485B (zh) * 2008-12-25 2011-11-23 中国医药集团总公司四川抗菌素工业研究所 吉西他滨脂质体及其制备方法
PL387296A1 (pl) * 2009-02-17 2010-08-30 Instytut Farmaceutyczny Sposób aktywnego zamykania amfifilowych substancji czynnych w strukturach liposomowych
DK177529B1 (en) 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
MX2012005677A (es) 2009-11-20 2012-08-23 Clavis Pharma Asa Formulaciones parentales de derivados de gemcitabina.
SI2508170T1 (sl) 2009-12-03 2015-12-31 Jiangsu Hengrui Medicine Co., Ltd. Liposom z irinotekanom ali njegovim hidrokloridom in njun postopek priprave
JP2013126953A (ja) * 2010-03-31 2013-06-27 Terumo Corp リポソーム製剤の製造方法
CN101822669B (zh) 2010-04-23 2012-06-13 海南美兰史克制药有限公司 一种阿莫西林钠舒巴坦钠药物组合物脂质体注射剂
EP2394640A1 (en) 2010-05-21 2011-12-14 MediGene AG Improved liposomal formulations of lipophilic compounds
CN101926779A (zh) 2010-08-19 2010-12-29 苏州特瑞药业有限公司 一种吉西他滨固体脂质纳米粒及其制备方法与用途
WO2012133121A1 (ja) 2011-03-25 2012-10-04 テルモ株式会社 持続徐放性リポソーム組成物およびその製造方法
JP5853453B2 (ja) 2011-07-15 2016-02-09 コニカミノルタ株式会社 リポソームを製造する方法
US8987224B2 (en) 2011-08-05 2015-03-24 Baylor College Of Medicine MicroRNA-198 as a tumor suppressor in pancreatic cancer
EP2773426B1 (en) 2011-10-31 2018-08-22 Mallinckrodt LLC Combinational liposome compositions for cancer therapy
EP2604253A1 (en) 2011-12-13 2013-06-19 Otto Glatter Water-in-oil emulsions and methods for their preparation
US9913822B2 (en) 2012-04-04 2018-03-13 Halozyme, Inc. Combination therapy with an anti-hyaluronan agent and therapeutic agent
CN102784107B (zh) * 2012-05-17 2015-04-22 江苏豪森药业股份有限公司 一种吉西他滨或其盐脂质体及其制备方法和用途
CN102716089B (zh) * 2012-06-29 2013-12-11 海南灵康制药有限公司 一种盐酸吉西他滨脂质体注射剂
AU2013360302C1 (en) 2012-12-12 2019-01-24 Temple University - Of The Commonwealth System Of Higher Education Compositions and methods for treatment of cancer
WO2014110555A1 (en) 2013-01-14 2014-07-17 Chemo-Enchanced Llc Compositions and methods for treating cancer
WO2014138278A1 (en) 2013-03-05 2014-09-12 The Regents Of The University Of California Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
KR20160066554A (ko) 2013-10-25 2016-06-10 파마싸이클릭스 엘엘씨 브루톤 타이로신 키나제 억제제 및 면역요법을 이용한 치료
ES2836772T3 (es) * 2014-04-30 2021-06-28 Fujifilm Corp Composición liposomal y método para producirla
PL3138556T3 (pl) 2014-04-30 2022-05-16 Fujifilm Corporation Sposób wytwarzania liposomu
EP3138557B1 (en) 2014-04-30 2023-06-07 FUJIFILM Corporation Liposome composition and method for producing same
EP3138558B1 (en) 2014-04-30 2023-06-07 FUJIFILM Corporation Liposome composition and production method therefor
CA2949121A1 (en) 2014-05-15 2015-11-19 Bristol-Myers Squibb Company Treatment of lung cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent
WO2016172494A2 (en) 2015-04-23 2016-10-27 The Johns Hopkins University Combination of immunotherapy with local chemotherapy for the treatment of malignancies
BR112017028287A2 (pt) 2015-06-29 2018-09-04 Syndax Pharmaceuticals Inc Combinação do inibidor hdac e anticorpido anti-pd- l1 para o tratamento do câncer
CN105012966B (zh) 2015-07-01 2018-11-02 南通厚元生物科技有限公司 吉西他滨-磷脂复合物的制备方法及其应用
EP3372223B1 (en) 2015-11-02 2024-04-17 FUJIFILM Corporation Liposome composition and method for producing same
ES2869283T3 (es) * 2015-11-02 2021-10-25 Fujifilm Corp Agente terapéutico antitumoral que contiene composición de liposoma de gemcitabina y kit
CN106955354B (zh) 2016-01-11 2020-06-19 中国科学院分子细胞科学卓越创新中心 用于肿瘤免疫治疗的联合用药物组合
WO2017192863A1 (en) 2016-05-04 2017-11-09 L.E.A.F. Holdings Group Llc Targeted liposomal gemcitabine compositions and methods thereof
BR112019007365A2 (pt) 2016-10-12 2019-07-09 Univ Texas métodos e composições para imunoterapia com tusc2
JP2019536805A (ja) 2016-12-05 2019-12-19 ジー１、セラピューティクス、インコーポレイテッドＧ１ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 化学療法計画中の免疫応答の保護

Also Published As

Publication number Publication date
PL3138555T3 (pl) 2021-04-06
US11684575B2 (en) 2023-06-27
JP6251385B2 (ja) 2017-12-20
WO2015166986A1 (ja) 2015-11-05
JPWO2015166986A1 (ja) 2017-04-20
CY1123731T1 (el) 2022-05-27
DK3138555T3 (da) 2020-12-14
EP3138555A4 (en) 2017-03-08
US20210100745A1 (en) 2021-04-08
RS61273B1 (sr) 2021-01-29
EP3138555B1 (en) 2020-10-28
US10391057B2 (en) 2019-08-27
US10898435B2 (en) 2021-01-26
US20190336447A1 (en) 2019-11-07
PT3138555T (pt) 2020-12-15
EP3138555A1 (en) 2017-03-08
SI3138555T1 (sl) 2021-06-30
LT3138555T (lt) 2021-03-25
ES2836772T3 (es) 2021-06-28
HRP20202030T1 (hr) 2021-02-19
US20170042811A1 (en) 2017-02-16

Similar Documents

Publication Publication Date Title
IL247963A0 (en) Solid forms of ibrutinib and process for their preparation
GB201410262D0 (en) Novel method
EP3103633B8 (en) Molded object and production method therefor
HK1208435A1 (en) Cement and manufacturing method thereof
SG11201507206TA (en) Formed material manufacturing method
EP3206263A4 (en) Terminal and production method therefor
GB2522923B (en) Insoles and production methods
PL3175539T3 (pl) Pakiet lamelek oraz sposób ich wytwarzania
HK1256241A1 (zh) 形象物以及形象物的製造方法
EP3138558A4 (en) Liposome composition and production method therefor
EP3138557A4 (en) Liposome composition and method for producing same
RS61273B1 (sr) Lipozomska kompozicija i postupak za njeno dobijanje
EP3235562C0 (en) METHOD AND DEVICE FOR MANUFACTURING LIPOSOMES
HK1243995A1 (zh) α-細辛醇酯及其製備方法與應用
SG11201609688QA (en) Formed material manufacturing method and formed material
GB201705822D0 (en) Proppant composition and method
SG11201507205UA (en) Formed material manufacturing method and formed material
IL246831B (en) A method for the production of 1-indanols and 1-indanamines
PL3235561T3 (pl) Sposób wytwarzania liposomów i urządzenie do wytwarzania liposomów
EP3085819A4 (en) Fabric production method and fabric
EP3132790A4 (en) Exenatide-containing composition and preparation method therefor
EP3109243A4 (en) GAMMA BUTYLOLACTONE COMPOSITION AND METHOD OF PREPARING THEREOF
GB201501762D0 (en) Composite component and method for its production
GB201416082D0 (en) Method and uses
PL2995872T3 (pl) Przekładka oraz sposób jej wytwarzania